Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of cytokeratin expression in human SK-BR-3 cells. Cells from the human SK-BR-3 (Breast adenocarcinoma, ATCC HTB-30) cell line were incubated with 1X BD FACS™ Lysing Solution (Cat. No. 349202), permeabilized with BD FACS™ Permeabilizing Solution 2 (Cat. No. 340973/347692), and washed with BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656). The cells were then stained with either Alexa Fluor® 647 Mouse Anti-Human Cytokeratin antibody (Cat. No. 563614; solid line histogram) or Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; dashed line histogram). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of cytokeratin expression in human SK-BR-3 cells. Cells from the human SK-BR-3 (Breast adenocarcinoma, ATCC HTB-30) cell line were incubated with 1X BD FACS™ Lysing Solution (Cat. No. 349202), permeabilized with BD FACS™ Permeabilizing Solution 2 (Cat. No. 340973/347692), and washed with BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656). The cells were then stained with either Alexa Fluor® 647 Mouse Anti-Human Cytokeratin antibody (Cat. No. 563614; solid line histogram) or Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; dashed line histogram). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of cytokeratin expression in human SK-BR-3 cells. Cells from the human SK-BR-3 (Breast adenocarcinoma, ATCC HTB-30) cell line were incubated with 1X BD FACS™ Lysing Solution (Cat. No. 349202), permeabilized with BD FACS™ Permeabilizing Solution 2 (Cat. No. 340973/347692), and washed with BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656). The cells were then stained with either Alexa Fluor® 647 Mouse Anti-Human Cytokeratin antibody (Cat. No. 563614; solid line histogram) or Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; dashed line histogram). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of cytokeratin expression in human SK-BR-3 cells. Cells from the human SK-BR-3 (Breast adenocarcinoma, ATCC HTB-30) cell line were incubated with 1X BD FACS™ Lysing Solution (Cat. No. 349202), permeabilized with BD FACS™ Permeabilizing Solution 2 (Cat. No. 340973/347692), and washed with BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656). The cells were then stained with either Alexa Fluor® 647 Mouse Anti-Human Cytokeratin antibody (Cat. No. 563614; solid line histogram) or Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; dashed line histogram). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of cytokeratin expression in human SK-BR-3 cells. Cells from the human SK-BR-3 (Breast adenocarcinoma, ATCC HTB-30) cell line were incubated with 1X BD FACS™ Lysing Solution (Cat. No. 349202), permeabilized with BD FACS™ Permeabilizing Solution 2 (Cat. No. 340973/347692), and washed with BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656). The cells were then stained with either Alexa Fluor® 647 Mouse Anti-Human Cytokeratin antibody (Cat. No. 563614; solid line histogram) or Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; dashed line histogram). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of cytokeratin expression in human SK-BR-3 cells. Cells from the human SK-BR-3 (Breast adenocarcinoma, ATCC HTB-30) cell line were incubated with 1X BD FACS™ Lysing Solution (Cat. No. 349202), permeabilized with BD FACS™ Permeabilizing Solution 2 (Cat. No. 340973/347692), and washed with BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656). The cells were then stained with either Alexa Fluor® 647 Mouse Anti-Human Cytokeratin antibody (Cat. No. 563614; solid line histogram) or Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; dashed line histogram). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Note: The CAM5.2 antibody can also be used to stain cells that have been fixed and permeabilized using BD Cytofix™ Fixation Buffer (Cat. No. 554655) and BD Perm/Wash™ Buffer (Cat. No. 554723).
The CAM5.2 monoclonal antibody specifically recognizes cytokeratin having a primary reactivity with human keratin proteins that correspond to Moll's peptides #7 (48 kDa) and #8 (52 kDa). Cytokeratin 7 and 8 are type II cytoskeletal keratins. These cytoskeletal proteins provide structural integrity for epithelial cells and may serve other functions as well. They are expressed in epithelia cells that comprise normal human tissues. Although these cytokeratins are not normally expressed in stratified squamous epithelium, they may be expressed in some squamous cell carcinomas. The CAM 5.2 antibody stains most epithelial-derived tissue, including liver, renal tubular epithelium, and hepatocellular and renal cell carcinomas.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.